Ex-Russian MP’s suspected assassin’s ‘double’ pops up in UkraineWorld March 24, 16:59
Photos of the week: Putin at the theater, Trump behind the wheel and Erdogan playing ballSociety & Culture March 24, 16:39
Legendary Soviet test pilot Mikoyan passes away at 94Military & Defense March 24, 16:22
Russian Aerospace Force received 16 Su-34 fighter bombers in 2016Military & Defense March 24, 16:06
Russian diplomat notes ultimatums cause Syrian opposition to suffer defeatsRussian Politics & Diplomacy March 24, 15:46
Putin and Le Pen did not talk about National Front's financing — KremlinRussian Politics & Diplomacy March 24, 15:07
Kremlin expects ex-Duma member’s murder to be investigated thoroughlyRussian Politics & Diplomacy March 24, 15:05
Putin backs Russian Central Bank's key rate cut and regulator’s strategyBusiness & Economy March 24, 14:45
Vatican museums make exception for Tretyakov Gallery exhibitionSociety & Culture March 24, 14:41
SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.
ResMed, a pioneer in the treatment of sleep-disordered breathing (SDB), has been the industry's premier innovator, with award winning customer-centric products that have significantly improved patient acceptance and adherence to SDB therapy.
Ecosystem Approach Brings Increased Efficiency and Efficacy to SDB Treatment
"With Air Solutions, we're creating a new beginning in patient care," said Don Darkin, president of the ResMed Sleep-Disordered Breathing Business Unit. "As we unveil each Air Solutions component, our signature differentiation of superior performance and comfort will be underscored, made even stronger with groundbreaking technology that helps providers become more connected with their patients."
Air Solutions comprises components that, together, create a comprehensive end-to-end ecosystem that directly addresses the pain points for each stakeholder in the patient's therapy, including physicians, sleep labs, home medical equipment providers, and the patients themselves. The ecosystem approach, Darkin says, can increase efficiency and treatment efficacy by keeping providers informed and patients engaged. Included in the Air Solutions platform are:
ApneaLink Air and AirFit masks are available now in the U.S. and other select markets. The AirSense 10 and AirView will be available in the U.S. and Australia on Aug. 18, and other markets later this calendar year. The AirCurve 10 Series and myAir will also be available later this calendar year.
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.
Contact for News Media:
Gretchen Griswold Director, Global Corporate Communications
Contact for Investors:
Agnes Lee Senior Director, Investor Relations